ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 136 filers reported holding ANAPTYSBIO INC in Q3 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $461,015 | +77.2% | 25,669 | +114.7% | 0.00% | – |
| Q1 2023 | $260,184 | -13.0% | 11,957 | +23.9% | 0.00% | – |
| Q4 2022 | $298,961 | +39.7% | 9,647 | +14.8% | 0.00% | – |
| Q3 2022 | $214,000 | -72.0% | 8,403 | -77.7% | 0.00% | – |
| Q2 2022 | $765,000 | +116.1% | 37,680 | +269.4% | 0.00% | – |
| Q4 2021 | $354,000 | +1.1% | 10,200 | -37.4% | 0.00% | – |
| Q4 2020 | $350,000 | +23.2% | 16,288 | -15.4% | 0.00% | – |
| Q3 2020 | $284,000 | -52.3% | 19,246 | -47.6% | 0.00% | -100.0% |
| Q4 2019 | $596,000 | +129.2% | 36,709 | +394.7% | 0.00% | – |
| Q3 2019 | $260,000 | +26.8% | 7,421 | +104.2% | 0.00% | – |
| Q2 2019 | $205,000 | -76.6% | 3,635 | -58.7% | 0.00% | -100.0% |
| Q3 2018 | $877,000 | -4.7% | 8,791 | -0.6% | 0.00% | 0.0% |
| Q1 2018 | $920,000 | +140.8% | 8,842 | +133.2% | 0.00% | +100.0% |
| Q4 2017 | $382,000 | – | 3,792 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $71,290,000 | 14.80% |
| EcoR1 Capital, LLC | 7,521,024 | $203,970,000 | 7.10% |
| GREAT POINT PARTNERS LLC | 549,545 | $14,904,000 | 3.47% |
| FRAZIER MANAGEMENT LLC | 899,700 | $24,400,000 | 1.95% |
| Boxer Capital, LLC | 1,300,000 | $35,256,000 | 1.23% |
| Palo Alto Investors LP | 436,592 | $11,840,000 | 0.72% |
| Woodline Partners LP | 1,013,956 | $27,498,000 | 0.45% |
| Cormorant Asset Management, LP | 385,081 | $10,443,000 | 0.42% |
| BVF INC/IL | 334,398 | $9,069,000 | 0.35% |
| Rock Springs Capital Management LP | 535,832 | $14,532,000 | 0.31% |